Detalhe da pesquisa
1.
Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations.
J Am Acad Dermatol
; 85(1): 38-45, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689776
2.
Clinical characteristics and management of clinically amyopathic juvenile dermatomyositis across four academic centers.
Pediatr Dermatol
; 38(2): 413-419, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438772
3.
Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA).
Pediatr Dermatol
; 38(2): 364-370, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33742457
4.
The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.
Immunity
; 28(3): 381-90, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18342009
5.
A survey of epidermolysis bullosa care in the United States and Canada.
Pediatr Dermatol
; 31(2): 169-75, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24456084
6.
Facial Eruption in a 5-year-Old Child with Acute Lymphoblastic Leukemia.
Pediatr Dermatol
; 33(6): 671-672, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27882670
7.
Congenital cutaneous Langerhans histiocytosis with mixed cell populations.
J Cutan Pathol
; 42(12): 1031-1033, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26094653
8.
Alopecia and generalized papular lesions in an adolescent female.
Pediatr Dermatol
; 29(4): 519-20, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22758379
9.
Cytokines elicited by T cell epitopes from a synovial autoantigen: altered peptide ligands can reduce interferon-gamma and interleukin-10 production.
Arthritis Rheum
; 48(8): 2375-85, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12905493
10.
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
Nat Immunol
; 5(10): 1052-60, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15334086